NFKB1 and diffuse large B-cell lymphoma: In order to identify drugs that inhibit NF-κB target gene expression and may thereby inhibit the proliferation and survival of DLBCL cells, we carried out a Connectivity Map analysis and identified doxycycline as a strong candidate.